Literature DB >> 7989292

Functional imaging in dementia: an overview.

W J Jagust1.   

Abstract

Functional brain imaging using both positron emission tomography and single photon emission computed tomography has been widely applied to the study of dementing diseases. This article reviews the basic approach of the clinician to the problem of dementia, which primarily entails the exclusion of treatable or reversible causes. Structural brain imaging using magnetic resonance imaging or computed tomography to search for reversible structural brain lesions is a key component of this evaluation. Functional imaging may provide clinicians with additional information helpful in establishing the cause of dementia after a reversible illness has been ruled out. Limitations in the data supporting the use of functional images still exist, however, and these images must be interpreted in the context of the overall clinical presentation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989292

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  4 in total

1.  Method to correlate 1H MRSI and 18FDG-PET.

Authors:  J O'Neill; J L Eberling; N Schuff; W Jagust; B Reed; G Soto; F Ezekiel; G Klein; M W Weiner
Journal:  Magn Reson Med       Date:  2000-02       Impact factor: 4.668

2.  Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD.

Authors:  N Schuff; A A Capizzano; A T Du; D L Amend; J O'Neill; D Norman; J Kramer; W Jagust; B Miller; O M Wolkowitz; K Yaffe; M W Weiner
Journal:  Neurology       Date:  2002-03-26       Impact factor: 9.910

Review 3.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

4.  Diagnosing dementia due to alzemier's disease : clinical perspective.

Authors:  N Kar; S Sengupta; P S Sharma
Journal:  Indian J Psychiatry       Date:  2000-07       Impact factor: 1.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.